Table 1 Demographic and clinical features of patients
Characteristics | Aloe (n = 19) | Placebo (n = 23) |
|---|---|---|
Age, mean ± SD (absolute range), y | 61.5 ± 13.1 | 63.3 ± 11.8 |
Male sex, No. (%) | 11 (57.9%) | 16 (69.6%) |
BMI, mean (SD), kg/m2 | 25.8 ± 3.2 | 25.3 ± 2.8 |
Dose of radiotherapy in each session, cGy | 181.5 ± 4.8 | 186.3 ± 9.3 |
Total dose of radiotherapy received, cGy | 5944.4 ± 1157.9 | 5721.7 ± 1111.2 |
Concomitant medication, No(%) | ||
 NSAIDs | 1 (5.3) | 1 (4.3) |
 Opioid | 2 (10.5) | 1 (4.3) |
 Anticholinergic | 0 (0) | 2 (8.7) |
 Alpha Blocker | 2 (10.5) | 2 (8.7) |
 Cardiovascular | 10 (52.6) | 8 (34.8) |
Condition, No(%) | ||
 HTN | 7 (36.8) | 6 (26.1) |
 Diabetes | 4 (21.05) | 8 (34.8) |
 Dyslipidemia | 2 (10.5) | 4 (17.4) |
 IHD | 2 (10.5) | 2 (8.7) |
 Pelvic Surgery | 4 (21.05) | 7 (30.4) |